カテゴリ： FactMR, 世界, 医療/バイオ

血液透析のグローバル市場2023～2033：サービス、薬剤、消耗品、機器

■ 英語タイトル：Hemodialysis Market Analysis By Product (Services, Drugs, Consumables, Equipment), By Modality (Conventional Long-term Hemodialysis, Short Daily Hemodialysis, Nocturnal Hemodialysis), By End User (Dialysis Centers, Hospitals, Home Care Settings), & By Region - Global Market Insights 2023 to 2033

調査会社FactMR社が発行したリサーチレポート（データ管理コード：FACT23AP092）■ 発行会社/調査会社：FactMR
■ 商品コード：FACT23AP092
■ 発行日：2023年1月24日
   最新版(2025年又は2026年)はお問い合わせください。
■ 調査対象地域：グローバル
■ 産業分野：医療
■ ページ数：約170
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール
■ 販売価格オプション（消費税別）
Single User（1名様閲覧、印刷不可）見積依頼/購入/質問フォーム
Global Sie License（同一拠点内共有可）見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※FactMR社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[血液透析のグローバル市場2023～2033：サービス、薬剤、消耗品、機器]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

Fact.MR社による最新調査レポートでは、世界の血液透析市場について2023年度から2033年度までの10年間にわたる市場規模予測を掲載しています。当書では、エグゼクティブサマリー、市場概要、市場リスク・動向分析、市場背景・基礎データ、需要分析・予測、製品別（サービス、薬剤、消耗品、機器）分析、モダリティ別（従来型長期血液透析、短日血液透析、夜間血液透析）分析、エンドユーザー別（透析センター、病院、在宅医療施設）分析、地域別（北米、中南米、ヨーロッパ、東アジア、南アジア＆オセアニア、中東/アフリカ）分析、市場構造分析、競争分析、仮定、調査方法などの項目を掲載しています。なお、当市場の主要企業には、Argon Medical Devices, Inc.、Asahi Kasei Medical Co., Ltd.、B. Braun Melsungen AGなどが含まれています。
・エグゼクティブサマリー
・市場概要
・市場リスク・動向分析
・市場背景・基礎データ
・需要分析・予測
・世界の血液透析市場規模：製品別
　- 血液透析サービスの市場規模
　- 血液透析薬剤の市場規模
　- 血液透析消耗品の市場規模
　- 血液透析機器の市場規模
・世界の血液透析市場規模：モダリティ別
　- 従来型長期血液透析の市場規模
　- 短日血液透析の市場規模
　- 夜間血液透析の市場規模
・世界の血液透析市場規模：エンドユーザー別
　- 透析センターにおける市場規模
　- 病院における市場規模
　- 在宅医療施設における市場規模
・世界の血液透析市場規模：地域別
　- 北米の血液透析市場規模
　- 中南米の血液透析市場規模
　- ヨーロッパの血液透析市場規模
　- 東アジアの血液透析市場規模
　- 南アジア＆オセアニアの血液透析市場規模
　- 中東/アフリカの血液透析市場規模
・市場構造分析
・競争分析
・仮定
・調査方法

本書は、各企業の製品ポートフォリオや主要戦略、包括的なSWOT分析などのエッセンスを含む企業情報を含んでいます。企業のプレゼンスは、すべての著名な市場参入者についてマッピングされ、マトリックスを通して提示されます。したがって、購読者に実用的なインサイトを提供し、熟考して市場状況などを提示し、血液透析における競争レベルを予想するのに有効です。

Hemodialysis Market – Scope of Report

A recent study by Fact.MR on the hemodialysis market offers a 10-year forecast for 2023 to 2033. The study analyzes crucial trends that are currently determining the growth of the market. This report explicates on vital dynamics, such as the drivers, restraints, and opportunities for key market players along with key stakeholders as well as emerging players associated with offering hemodialysis.

The study also provides the dynamics responsible for influencing the future status of the hemodialysis market over the forecast period. A detailed assessment of value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report.

A list of prominent companies operating in the hemodialysis market, along with their product portfolios, key strategies and SWOT analysis, enhances the reliability of this comprehensive research study.

Report Summary

The study offers comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales of hemodialysis across the globe.

A comprehensive estimate on the market has been provided through an optimistic as well as a conservative scenario, taking into account the sales of hemodialysis during the forecast period. Price point comparison by region with global average price is also considered in the study.

Analysis on Market Size Evaluation

The market has been analyzed for each segment in terms of value (US$ Mn).

Estimates at global and regional levels for hemodialysis are available in terms of “US$ Mn” for value. A Y-o-Y growth contrast on prominent market segments, along with market attractiveness evaluation, has been incorporated in the report. Furthermore, absolute dollar opportunity analysis of all the segments adds prominence to the report.

Absolute dollar opportunity plays a crucial role in assessing the level of opportunity that a manufacturer/distributor can look to achieve, along with identifying potential resources, considering the sales and distribution perspective in the global hemodialysis market.

Inspected Assessment on Regional Segments

Key sections have been elaborated in the report, which have helped deliver projections on regional markets. These chapters include regional macros (political, economic, and business environment outlook), which are expected to have a momentous influence on the growth of the hemodialysis market during the forecast period.

Country-specific valuation on demand for hemodialysis has been offered for each region, along with market scope estimates and forecasts, price index, and impact analysis of the dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.

Detailed breakup in terms of value & volume for emerging countries has also been included in the report.

In-depth Analysis on Competition

The report sheds light on leading manufacturers of hemodialysis, along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in offering hemodialysis has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.

Company profiles have been included in the report, which include essentials such as product portfolios and key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting the market status, and predicting the competition level in the hemodialysis domain.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1. Global Market – Executive Summary

    1.1. Global Market Overview

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Fact.MR Analysis and Recommendations

2. Global Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Introduction and Definition

3. Market Risks and Trends Assessment

    3.1. Risk Assessment

        3.1.1. COVID-19 Crisis and Impact on

        3.1.2. COVID-19 Crisis and Impact on Aprotic Solvent Prices

        3.1.3. COVID-19 Impact Benchmark with Previous Crisis

            3.1.3.1. Change in Demand

            3.1.3.2. Before and After COVID-19 Crisis (Projected)

            3.1.3.3. Before and After Sub-prime Crisis – 2008 (Actual)

            3.1.3.4. Change in Demand post Recovery Period (After Each Crisis)

        3.1.4. Impact on Market and Value (US$ Mn)

            3.1.4.1. Likely Loss of Value in 2022

            3.1.4.2. Mid-term and Long Term Forecast

            3.1.4.3. Quarter by Quarter Demand and Recovery Assessment

        3.1.5. Anticipated Demand and Value Recovery Curve

            3.1.5.1. Likelihood of U-Shape Recovery

            3.1.5.2. Likelihood of L-Shape Recovery

        3.1.6. Recovery Period Assessment by Key Countries

        3.1.7. Recovery Assessment by Key Market Segments

        3.1.8. Action Points and Recommendations for Suppliers

        3.1.9. Impact on Trade Balance

    3.2. Key Trends Impacting the Market

    3.3. Formulation and Modality Development Trends

4. Market Background and foundation Data Points

    4.1. Need of the Hour for Industries

    4.2. Industry Wise Industry 4.0

    4.3. Strategic Priorities

    4.4. Life Cycle Stage

    4.5. Importance of Technology

    4.6. Use Cases of Hemodialysis

    4.7. Forecast Factors: Relevance and Impact

    4.8. Investment Feasibility Matrix

    4.9. PESTLE Analysis

    4.10. Porter’s Five Forces Analysis

    4.11. Market Dynamics

        4.11.1. Drivers

        4.11.2. Restraints

        4.11.3. Opportunity Analysis

        4.11.4. Trend

5. Global Market Demand (US$ Mn) Analysis 2018 to 2022 and Forecast, 2023 to 2033

    5.1. Historical Market Value (US$ Mn) Analysis, 2018 to 2022

    5.2. Current and Future Market Value (US$ Mn) Projections, 2023 to 2033

        5.2.1. Y-o-Y Growth Trend Analysis

        5.2.2. Absolute $ Opportunity Analysis

6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Modality

    6.1. Introduction / Key Findings

    6.2. Historical Market Value (US$ Mn) Analysis By Modality, 2018 to 2022

    6.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Modality, 2023 to 2033

        6.3.1. Conventional Long-term Hemodialysis

        6.3.2. Short Daily Hemodialysis

        6.3.3. Nocturnal Hemodialysis

    6.4. Market Attractiveness Analysis By Modality

7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by Product

    7.1. Introduction / Key Findings

    7.2. Historical Market Value (US$ Mn) Analysis By Product , 2018 to 2022

    7.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Product, 2023 to 2033

        7.3.1. Services

        7.3.2. Drugs

        7.3.3. Consumables

        7.3.4. Equipment

    7.4. Market Attractiveness Analysis By Product

8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by End User

    8.1. Introduction / Key Findings

    8.2. Historical Market Value (US$ Mn) Analysis By End User, 2018 to 2022

    8.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By End User, 2023 to 2033

        8.3.1. Dialysis Centers

        8.3.2. Hospitals

        8.3.3. Home Care Settings

    8.4. Market Attractiveness Analysis By End User

9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by Region

    9.1. Introduction / Key Findings

    9.2. Historical Market Value (US$ Mn) Analysis By Region, 2018 to 2022

    9.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2023 to 2033

        9.3.1. North America

        9.3.2. Latin America

        9.3.3. Europe

        9.3.4. East Asia

        9.3.5. South Asia & Oceania

        9.3.6. Middle East and Africa (MEA)

    9.4. Market Attractiveness Analysis By Region

10. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033

    10.1. Introduction / Key Findings

    10.2. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022

    10.3. Market Value (US$ Mn) Forecast By Market Taxonomy, 2023 to 2033

        10.3.1. By Country

            10.3.1.1. United States

            10.3.1.2. Canada

        10.3.2. By Modality

        10.3.3. By Product

    10.4. Market Attractiveness Analysis

        10.4.1. By Country

        10.4.2. By Modality

        10.4.3. By Product

11. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022

    11.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2023 to 2033

        11.3.1. By Country

            11.3.1.1. Brazil

            11.3.1.2. Mexico

            11.3.1.3. Rest of Latin America

        11.3.2. By Modality

        11.3.3. By Product

        11.3.4. By End User

    11.4. Market Attractiveness Analysis

        11.4.1. By Country

        11.4.2. By Modality

        11.4.3. By Product

        11.4.4. By End User

12. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033

    12.1. Introduction / Key Findings

    12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022

    12.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2023 to 2033

        12.3.1. By Country

            12.3.1.1. Germany

            12.3.1.2. France

            12.3.1.3. Italy

            12.3.1.4. Spain

            12.3.1.5. United Kingdom

            12.3.1.6. BENELUX

            12.3.1.7. Russia

            12.3.1.8. Rest of Europe

        12.3.2. By Modality

        12.3.3. By Product

        12.3.4. By End User

    12.4. Market Attractiveness Analysis

        12.4.1. By Country

        12.4.2. By Modality

        12.4.3. By Product

        12.4.4. By End User

13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033

    13.1. Introduction / Key Findings

    13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022

    13.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2023 to 2033

        13.3.1. By Country

            13.3.1.1. China

            13.3.1.2. Japan

            13.3.1.3. South Korea

        13.3.2. By Modality

        13.3.3. By Product

        13.3.4. By End User

    13.4. Market Attractiveness Analysis

        13.4.1. By Country

        13.4.2. By Modality

        13.4.3. By Product

        13.4.4. By End User

14. South Asia & Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033

    14.1. Introduction / Key Findings

    14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022

    14.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2023 to 2033

        14.3.1. By Country

            14.3.1.1. India

            14.3.1.2. Thailand

            14.3.1.3. Malaysia

            14.3.1.4. Singapore

            14.3.1.5. Vietnam

            14.3.1.6. ANZ

            14.3.1.7. Rest of South Asia & Oceania

        14.3.2. By Modality

        14.3.3. By Product

        14.3.4. By End User

    14.4. Market Attractiveness Analysis

        14.4.1. By Country

        14.4.2. By Modality

        14.4.3. By Product

        14.4.4. By End User

15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033

    15.1. Introduction / Key Findings

    15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022

    15.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2023 to 2033

        15.3.1. By Country

            15.3.1.1. GCC Countries

            15.3.1.2. South Africa

            15.3.1.3. Israel

            15.3.1.4. Rest of Middle East and Africa (MEA)

        15.3.2. By Modality

        15.3.3. By Product

        15.3.4. By End User

    15.4. Market Attractiveness Analysis

        15.4.1. By Country

        15.4.2. By Modality

        15.4.3. By Product

        15.4.4. By End User

16. Market Structure Analysis

    16.1. Market Analysis by Tier of Companies

    16.2. Market Concentration

    16.3. Market Share Analysis of Top Players

    16.4. Market Presence Analysis

17. Competition Analysis

    17.1. Competition Dashboard

    17.2. Competition Benchmarking

    17.3. Competition Deep Dive

        17.3.1. Argon Medical Devices, Inc.

            17.3.1.1. Company Overview

            17.3.1.2. Modality overview

            17.3.1.3. SWOT Analysis

            17.3.1.4. Key Developments

        17.3.2. Asahi Kasei Medical Co., Ltd.

            17.3.2.1. Company Overview

            17.3.2.2. Modality overview

            17.3.2.3. SWOT Analysis

            17.3.2.4. Key Developments

        17.3.3. B. Braun Melsungen AG

            17.3.3.1. Company Overview

            17.3.3.2. Modality overview

            17.3.3.3. SWOT Analysis

            17.3.3.4. Key Developments

        17.3.4. BARD, A Becton, Dickinson Company

            17.3.4.1. Company Overview

            17.3.4.2. Modality overview

            17.3.4.3. SWOT Analysis

            17.3.4.4. Key Developments

        17.3.5. Baxter International, Inc.

            17.3.5.1. Company Overview

            17.3.5.2. Modality overview

            17.3.5.3. SWOT Analysis

            17.3.5.4. Key Developments

        17.3.6. DaVita Healthcare Partners, Inc.

            17.3.6.1. Company Overview

            17.3.6.2. Modality overview

            17.3.6.3. SWOT Analysis

            17.3.6.4. Key Developments

        17.3.7. Fresenius Medical Care AG & Co. KgaA

            17.3.7.1. Company Overview

            17.3.7.2. Modality overview

            17.3.7.3. SWOT Analysis

            17.3.7.4. Key Developments

        17.3.8. Kawasumi Laboratories, Inc.

            17.3.8.1. Company Overview

            17.3.8.2. Modality overview

            17.3.8.3. SWOT Analysis

            17.3.8.4. Key Developments

        17.3.9. Medical Components, Inc.

            17.3.9.1. Company Overview

            17.3.9.2. Modality overview

            17.3.9.3. SWOT Analysis

            17.3.9.4. Key Developments

        17.3.10. Merit Medical Systems, Inc.

            17.3.10.1. Company Overview

            17.3.10.2. Modality overview

            17.3.10.3. SWOT Analysis

            17.3.10.4. Key Developments

        17.3.11. Nikkiso Co., Ltd.

            17.3.11.1. Company Overview

            17.3.11.2. Modality overview

            17.3.11.3. SWOT Analysis

            17.3.11.4. Key Developments

        17.3.12. Nipro Corporation

            17.3.12.1. Company Overview

            17.3.12.2. Modality overview

            17.3.12.3. SWOT Analysis

            17.3.12.4. Key Developments

        17.3.13. Teleflex, Inc.

            17.3.13.1. Company Overview

            17.3.13.2. Modality overview

            17.3.13.3. SWOT Analysis

            17.3.13.4. Key Developments

18. Assumptions And Acronyms Used

19. Research Methodology

Table 1: Global Market Value (US$ Mn) Analysis, by Modality, 2018 to 2022

Table 2: Global Market Value (US$ Mn) Analysis, by Modality, 2023 to 2033

Table 3: Global Market Value (US$ Mn) Opportunity Analysis, by Modality, 2023 to 2033

Table 4: Global Market Value (US$ Mn) Analysis, by Product, 2018 to 2022

Table 5: Global Market Value (US$ Mn) Analysis, by Product, 2023 to 2033

Table 6: Global Market Value (US$ Mn) Opportunity Analysis, by Product, 2023 to 2033

Table 7: Global Market Value (US$ Mn) Analysis, by End User, 2018 to 2022

Table 8: Global Market Value (US$ Mn) Analysis, by End User, 2023 to 2033

Table 9: Global Market Value (US$ Mn) Opportunity Analysis, by End User, 2023 to 2033

Table 10: Global Market Value (US$ Mn) Analysis, by Region, 2018 to 2022

Table 11: Global Market Value (US$ Mn) Analysis, by Region, 2023 to 2033

Table 12: Global Market Value (US$ Mn) Opportunity Analysis, by Region, 2023 to 2033

Table 13: North America Market Value (US$ Mn) Analysis, by Country, 2018 to 2022

Table 14: North America Market Value (US$ Mn) Analysis, by Country, 2023 to 2033

Table 15: North America Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033

Table 16: North America Market Value (US$ Mn) Analysis, by Modality, 2018 to 2022

Table 17: North America Market Value (US$ Mn) Analysis, by Modality, 2023 to 2033

Table 18: North America Market Value (US$ Mn) Opportunity Analysis, by Modality, 2023 to 2033

Table 19: North America Market Value (US$ Mn) Analysis, by Product, 2018 to 2022

Table 20: North America Market Value (US$ Mn) Analysis, by Product, 2023 to 2033

Table 21: North America Market Value (US$ Mn) Opportunity Analysis, by Product, 2023 to 2033

Table 22: North America Market Value (US$ Mn) Analysis, by End User, 2018 to 2022

Table 23: North America Market Value (US$ Mn) Analysis, by End User, 2023 to 2033

Table 24: North America Market Value (US$ Mn) Opportunity Analysis, by End User, 2023 to 2033

Table 25: Latin America Market Value (US$ Mn) Analysis, by Country, 2018 to 2022

Table 26: Latin America Market Value (US$ Mn) Analysis, by Country, 2023 to 2033

Table 27: Latin America Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033

Table 28: Latin America Market Value (US$ Mn) Analysis, by Modality, 2018 to 2022

Table 29: Latin America Market Value (US$ Mn) Analysis, by Modality, 2023 to 2033

Table 30: Latin America Market Value (US$ Mn) Opportunity Analysis, by Modality, 2023 to 2033

Table 31: Latin America Market Value (US$ Mn) Analysis, by Product, 2018 to 2022

Table 32: Latin America Market Value (US$ Mn) Analysis, by Product, 2023 to 2033

Table 33: Latin America Market Value (US$ Mn) Opportunity Analysis, by Product, 2023 to 2033

Table 34: Latin America Market Value (US$ Mn) Analysis, by End User, 2018 to 2022

Table 35: Latin America Market Value (US$ Mn) Analysis, by End User, 2023 to 2033

Table 36: Latin America Market Value (US$ Mn) Opportunity Analysis, by End User, 2023 to 2033

Table 37: Europe Market Value (US$ Mn) Analysis, by Country, 2018 to 2022

Table 38: Europe Market Value (US$ Mn) Analysis, by Country, 2023 to 2033

Table 39: Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033

Table 40: Europe Market Value (US$ Mn) Analysis, by Modality, 2018 to 2022

Table 41: Europe Market Value (US$ Mn) Analysis, by Modality, 2023 to 2033

Table 42: Europe Market Value (US$ Mn) Opportunity Analysis, by Modality, 2023 to 2033

Table 43: Europe Market Value (US$ Mn) Analysis, by Product, 2018 to 2022

Table 44: Europe Market Value (US$ Mn) Analysis, by Product, 2023 to 2033

Table 45: Europe Market Value (US$ Mn) Opportunity Analysis, by Product, 2023 to 2033

Table 46: Europe Market Value (US$ Mn) Analysis, by End User, 2018 to 2022

Table 47: Europe Market Value (US$ Mn) Analysis, by End User, 2023 to 2033

Table 48: Europe Market Value (US$ Mn) Opportunity Analysis, by End User, 2023 to 2033

Table 49: East Asia Market Value (US$ Mn) Analysis, by Country, 2018 to 2022

Table 50: East Asia Market Value (US$ Mn) Analysis, by Country, 2023 to 2033

Table 51: East Asia Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033

Table 52: East Asia Market Value (US$ Mn) Analysis, by Modality, 2018 to 2022

Table 53: East Asia Market Value (US$ Mn) Analysis, by Modality, 2023 to 2033

Table 54: East Asia Market Value (US$ Mn) Opportunity Analysis, by Modality, 2023 to 2033

Table 55: East Asia Market Value (US$ Mn) Analysis, by Product, 2018 to 2022

Table 56: East Asia Market Value (US$ Mn) Analysis, by Product, 2023 to 2033

Table 57: East Asia Market Value (US$ Mn) Opportunity Analysis, by Product, 2023 to 2033

Table 58: East Asia Market Value (US$ Mn) Analysis, by End User, 2018 to 2022

Table 59: East Asia Market Value (US$ Mn) Analysis, by End User, 2023 to 2033

Table 60: East Asia Market Value (US$ Mn) Opportunity Analysis, by End User, 2023 to 2033

Table 61: South Asia & Oceania Market Value (US$ Mn) Analysis, by Country, 2018 to 2022

Table 62: South Asia & Oceania Market Value (US$ Mn) Analysis, by Country, 2023 to 2033

Table 63: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033

Table 64: South Asia & Oceania Market Value (US$ Mn) Analysis, by Modality, 2018 to 2022

Table 65: South Asia & Oceania Market Value (US$ Mn) Analysis, by Modality, 2023 to 2033

Table 66: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Modality, 2023 to 2033

Table 67: South Asia & Oceania Market Value (US$ Mn) Analysis, by Product, 2018 to 2022

Table 68: South Asia & Oceania Market Value (US$ Mn) Analysis, by Product, 2023 to 2033

Table 69: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Product, 2023 to 2033

Table 70: South Asia & Oceania Market Value (US$ Mn) Analysis, by End User, 2018 to 2022

Table 71: South Asia & Oceania Market Value (US$ Mn) Analysis, by End User, 2023 to 2033

Table 72: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by End User, 2023 to 2033

Table 73: MEA Market Value (US$ Mn) Analysis, by Country, 2018 to 2022

Table 74: MEA Market Value (US$ Mn) Analysis, by Country, 2023 to 2033

Table 75: MEA Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033

Table 76: MEA Market Value (US$ Mn) Analysis, by Modality, 2018 to 2022

Table 77: MEA Market Value (US$ Mn) Analysis, by Modality, 2023 to 2033

Table 78: MEA Market Value (US$ Mn) Opportunity Analysis, by Modality, 2023 to 2033

Table 79: MEA Market Value (US$ Mn) Analysis, by Product, 2018 to 2022

Table 80: MEA Market Value (US$ Mn) Analysis, by Product, 2023 to 2033

Table 81: MEA Market Value (US$ Mn) Opportunity Analysis, by Product, 2023 to 2033

Table 82: MEA Market Value (US$ Mn) Analysis, by End User, 2018 to 2022

Table 83: MEA Market Value (US$ Mn) Analysis, by End User, 2023 to 2033

Table 84: MEA Market Value (US$ Mn) Opportunity Analysis, by End User, 2023 to 2033
※参考情報

血液透析は、腎不全などによって腎臓が正常に機能しない場合に行われる治療法の一つです。腎臓は体内の老廃物や余分な水分を排除する重要な臓器ですが、その機能が低下すると、血液中に毒素が蓄積し、さまざまな健康障害を引き起こす可能性があります。血液透析は、人工的に血液を浄化する手段として広く用いられています。

血液透析の主な種類には、外来透析と入院透析があります。外来透析は、透析施設に通院して受けるもので、通常は週に数回、一定の時間帯に行われます。患者は自宅から透析施設へ通い、専門の医療スタッフによって治療を受けます。一方、入院透析は、重症の患者が入院中に行われる透析であり、より継続的な監視が必要な場合に選択されます。

血液透析の用途は、主に慢性腎不全や急性腎不全に対する治療です。慢性腎不全においては、腎機能が徐々に低下するため、定期的な透析が必要になります。急性腎不全では、急激な腎機能の低下があり、短期間の透析が有効です。また、透析は一時的な治療法としても用いられ、腎機能が回復するのを待つ間に老廃物を排毒する役割も果たします。

血液透析のプロセスは、主に三つのステップから成り立っています。最初に、患者の血液を透析装置に引き込みます。この過程では、血液が体外に出され、人工的な膜を介して浄化されます。この膜は、老廃物や余分な塩分を血液から選択的に除去するためのフィルターの役割を果たします。次に透析液が用いられ、透析膜を介して老廃物を吸収します。そして最後に、浄化された血液が再び患者の体内に戻されます。

関連技術としては、持続的腎代替療法（CKRT）や腹膜透析があります。持続的腎代替療法は、特に重症患者において、より長期間にわたって腎機能をサポートする方法です。これに対し腹膜透析は、腹腔に透析液を注入し、腹膜をフィルターとして利用する方法で、自己管理が可能であるため患者のライフスタイルに柔軟性をもたらします。

近年、血液透析の分野では、技術革新が進んでいます。例えば、オンライン透析と呼ばれる新しいアプローチは、透析中に血液中の代謝物質をリアルタイムでモニタリングし、透析液の組成を調整することが可能です。また、透析機器の自動化が進んでおり、より効率的かつ快適な治療が実現されています。

さらに、血液透析を受ける患者の生活の質を向上させるための取り組みも進んでいます。例えば、患者教育が重要視されており、食事や運動に関する情報提供が行われています。患者自身が治療に積極的に関与することが、治療の成果を高める要因となります。

血液透析は、腎機能が低下した患者にとって命を繋ぐ重要な治療法です。その効果を最大限に引き出すためには、医療スタッフとの密なコミュニケーションや自己管理の意識が不可欠です。これらの要素が組み合わさることで、患者がより健康的な生活を送ることができるのです。治療の進歩とともに、血液透析への理解を深め、適切な管理を行うことが重要です。


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • データファブリックのグローバル市場2023～2033：ソフトウェア、サービス
  • 6Gのグローバル市場2023～2033：ハードウェア、ソフトウェア、サービス
  • 非破壊検査のグローバル市場（~2033）：サービス、機器
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(FACT23AP092 )"血液透析のグローバル市場2023～2033：サービス、薬剤、消耗品、機器" (英文：Hemodialysis Market Analysis By Product (Services, Drugs, Consumables, Equipment), By Modality (Conventional Long-term Hemodialysis, Short Daily Hemodialysis, Nocturnal Hemodialysis), By End User (Dialysis Centers, Hospitals, Home Care Settings), & By Region - Global Market Insights 2023 to 2033)はFactMR社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。